Loading…

Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review

In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current...

Full description

Saved in:
Bibliographic Details
Published in:Heart Asia 2019-06, Vol.11 (2), p.e011173-e011173
Main Authors: Ni, Zhao, Dardas, Latefa, Wu, Bei, Shaw, Ryan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373
cites cdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373
container_end_page e011173
container_issue 2
container_start_page e011173
container_title Heart Asia
container_volume 11
creator Ni, Zhao
Dardas, Latefa
Wu, Bei
Shaw, Ryan
description In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.
doi_str_mv 10.1136/heartasia-2018-011173
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6590990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2246742184</sourcerecordid><originalsourceid>FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhSMEolXpTwBZ4sIl4HGcOOaAhFZAK1XiAmdrYk8arzb2Yme36r-vly2rwglfbI2_eXpPr6peA38P0HQfJsK0YPZYCw59zQFANc-qc1CtrgG4fP7kfVZd5rzm5TQgeyleVmcNCK2gE-dVWGFyPm5TXMgufk9sJuctLj4Ghm6iRMESwzmGW7YtYwpLZnd-mZiNKQZM9-y3G-Z8JszEfGCryQf8yJDl-7zQXLYsS7T3dPeqejHiJtPl431R_fz65cfqqr75_u169fmmHmTPlxpb3jvZqlFr23aKK0vaWacHxF4Oo9TQ617gaLkbCZwAqUaQIBGRbNeo5qL6dNTd7oYSyBbXCTdmm_xcHJuI3vz9E_xkbuPedK3mWvMi8O5RIMVfO8qLmX22tNlgoLjLRohWKd5ycUDf_oOu4y6FEq9QslNSQC8L1R4pm2LOicaTGeDmUKo5lWoOpZpjqWXvzdMkp60_FRaAH4FhXv-n5gPzOrI1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2246742184</pqid></control><display><type>article</type><title>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</title><source>PubMed</source><creator>Ni, Zhao ; Dardas, Latefa ; Wu, Bei ; Shaw, Ryan</creator><creatorcontrib>Ni, Zhao ; Dardas, Latefa ; Wu, Bei ; Shaw, Ryan</creatorcontrib><description>In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.</description><identifier>ISSN: 1759-1104</identifier><identifier>EISSN: 1759-1104</identifier><identifier>DOI: 10.1136/heartasia-2018-011173</identifier><identifier>PMID: 31297162</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Acute coronary syndromes ; Cardiology ; Cardiovascular disease ; Coronary vessels ; Global health ; Health care access ; Health risk assessment ; Heart ; Intervention ; Keywords ; Nursing ; Patient compliance ; Pharmaceuticals ; Public health ; Review ; Systematic review</subject><ispartof>Heart Asia, 2019-06, Vol.11 (2), p.e011173-e011173</ispartof><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</citedby><cites>FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</cites><orcidid>0000-0001-5437-4778 ; 0000-0002-9185-9894</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590990/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590990/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31297162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ni, Zhao</creatorcontrib><creatorcontrib>Dardas, Latefa</creatorcontrib><creatorcontrib>Wu, Bei</creatorcontrib><creatorcontrib>Shaw, Ryan</creatorcontrib><title>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</title><title>Heart Asia</title><addtitle>Heart Asia</addtitle><description>In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.</description><subject>Acute coronary syndromes</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Coronary vessels</subject><subject>Global health</subject><subject>Health care access</subject><subject>Health risk assessment</subject><subject>Heart</subject><subject>Intervention</subject><subject>Keywords</subject><subject>Nursing</subject><subject>Patient compliance</subject><subject>Pharmaceuticals</subject><subject>Public health</subject><subject>Review</subject><subject>Systematic review</subject><issn>1759-1104</issn><issn>1759-1104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqNkUFv1DAQhSMEolXpTwBZ4sIl4HGcOOaAhFZAK1XiAmdrYk8arzb2Yme36r-vly2rwglfbI2_eXpPr6peA38P0HQfJsK0YPZYCw59zQFANc-qc1CtrgG4fP7kfVZd5rzm5TQgeyleVmcNCK2gE-dVWGFyPm5TXMgufk9sJuctLj4Ghm6iRMESwzmGW7YtYwpLZnd-mZiNKQZM9-y3G-Z8JszEfGCryQf8yJDl-7zQXLYsS7T3dPeqejHiJtPl431R_fz65cfqqr75_u169fmmHmTPlxpb3jvZqlFr23aKK0vaWacHxF4Oo9TQ617gaLkbCZwAqUaQIBGRbNeo5qL6dNTd7oYSyBbXCTdmm_xcHJuI3vz9E_xkbuPedK3mWvMi8O5RIMVfO8qLmX22tNlgoLjLRohWKd5ycUDf_oOu4y6FEq9QslNSQC8L1R4pm2LOicaTGeDmUKo5lWoOpZpjqWXvzdMkp60_FRaAH4FhXv-n5gPzOrI1</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Ni, Zhao</creator><creator>Dardas, Latefa</creator><creator>Wu, Bei</creator><creator>Shaw, Ryan</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5437-4778</orcidid><orcidid>https://orcid.org/0000-0002-9185-9894</orcidid></search><sort><creationdate>20190601</creationdate><title>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</title><author>Ni, Zhao ; Dardas, Latefa ; Wu, Bei ; Shaw, Ryan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acute coronary syndromes</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Coronary vessels</topic><topic>Global health</topic><topic>Health care access</topic><topic>Health risk assessment</topic><topic>Heart</topic><topic>Intervention</topic><topic>Keywords</topic><topic>Nursing</topic><topic>Patient compliance</topic><topic>Pharmaceuticals</topic><topic>Public health</topic><topic>Review</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ni, Zhao</creatorcontrib><creatorcontrib>Dardas, Latefa</creatorcontrib><creatorcontrib>Wu, Bei</creatorcontrib><creatorcontrib>Shaw, Ryan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (ProQuest Medical &amp; Health Databases)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heart Asia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ni, Zhao</au><au>Dardas, Latefa</au><au>Wu, Bei</au><au>Shaw, Ryan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</atitle><jtitle>Heart Asia</jtitle><addtitle>Heart Asia</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>11</volume><issue>2</issue><spage>e011173</spage><epage>e011173</epage><pages>e011173-e011173</pages><issn>1759-1104</issn><eissn>1759-1104</eissn><abstract>In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>31297162</pmid><doi>10.1136/heartasia-2018-011173</doi><orcidid>https://orcid.org/0000-0001-5437-4778</orcidid><orcidid>https://orcid.org/0000-0002-9185-9894</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1759-1104
ispartof Heart Asia, 2019-06, Vol.11 (2), p.e011173-e011173
issn 1759-1104
1759-1104
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6590990
source PubMed
subjects Acute coronary syndromes
Cardiology
Cardiovascular disease
Coronary vessels
Global health
Health care access
Health risk assessment
Heart
Intervention
Keywords
Nursing
Patient compliance
Pharmaceuticals
Public health
Review
Systematic review
title Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A03%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardioprotective%20medication%20adherence%20among%20patients%20with%20coronary%20heart%20disease%20in%20China:%20a%20systematic%20review&rft.jtitle=Heart%20Asia&rft.au=Ni,%20Zhao&rft.date=2019-06-01&rft.volume=11&rft.issue=2&rft.spage=e011173&rft.epage=e011173&rft.pages=e011173-e011173&rft.issn=1759-1104&rft.eissn=1759-1104&rft_id=info:doi/10.1136/heartasia-2018-011173&rft_dat=%3Cproquest_pubme%3E2246742184%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2246742184&rft_id=info:pmid/31297162&rfr_iscdi=true